Page last updated: 2024-09-05

sb 203580 and alpha bitter acid

sb 203580 has been researched along with alpha bitter acid in 1 studies

Compound Research Comparison

Studies
(sb 203580)
Trials
(sb 203580)
Recent Studies (post-2010)
(sb 203580)
Studies
(alpha bitter acid)
Trials
(alpha bitter acid)
Recent Studies (post-2010) (alpha bitter acid)
3,48941,13767131

Protein Interaction Comparison

ProteinTaxonomysb 203580 (IC50)alpha bitter acid (IC50)
Polyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)9.3

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Capasso, A; D'Acunto, CW; Festa, M; Masullo, M; Piacente, S; Pizza, C; Rossi, AG1

Other Studies

1 other study(ies) available for sb 203580 and alpha bitter acid

ArticleYear
Xanthohumol induces apoptosis in human malignant glioblastoma cells by increasing reactive oxygen species and activating MAPK pathways.
    Journal of natural products, 2011, Dec-27, Volume: 74, Issue:12

    Topics: Acetylcysteine; Antineoplastic Agents; Apoptosis; Caspase 3; Caspase 9; Cyclohexenes; Cytochromes c; Dose-Response Relationship, Drug; Flavonoids; Glioblastoma; Humans; Imidazoles; Italy; Mitogen-Activated Protein Kinases; Molecular Structure; Poly(ADP-ribose) Polymerases; Propiophenones; Pyridines; Reactive Oxygen Species; Terpenes

2011